Ausgabe 4/2001
Inhalt (9 Artikel)
The introduction of pharmacoeconomic analysis in Norway ― are the users prepared?
Elisabeth Moen Rørvik, Else-Lydia Toverud, Lars. Walløe
Number of non‐diabetic drugs: a simple comorbidity indicator for diabetes?
P. M. Whitty, M. P Eccles, I. N. Steen, E. McColl, A. Hutchinson, K. Meadows, J. Hewison
Evaluation of antiparkinsonian drugs in pharmacy records as a marker for Parkinson's disease
D.A.M.C. van de Vijver, A.J. Porsius, A. de Boer, B.H.Ch. Stricker, M.M.B. Breteler, R.A.C. Roos MD, J. Hewison
Polypharmacy among patients admitted to hospital with rheumatic diseases
Kirsten K. Viktil, Merethe Enstad, Janne Kutschera, Liv Marit Smedstad, Jan Schjott
The role of the Danish community pharmacist: perceptions and future scenarios
Lotte Stig Nørgaard, Lene Colberg, Mie Riise Niemann